Fuel Tech (FTEK) Q1 2025 earnings summary

Executive summary

• Revenue increased 29% year-over-year to $6.4 million, driven by a 92% rise in FUEL CHEM segment revenue and new APC project awards, resulting in the best Q1 for Fuel Chem in over a decade.

• Gross margin improved to 46% from 41% year-over-year, with FUEL CHEM gross margin at 50%.

• Net loss for the quarter was $739,000 ($0.02/share), compared to net income of $281,000 ($0.01/share) last year, which included a $1.7 million one-time ERC benefit.

• Strong financial position maintained with $31.2 million in cash, cash equivalents, and investments, and no long-term debt at quarter end.

• Significant growth in business development opportunities, especially in emissions control for power generation, water technology, and data center markets.

Financial highlights

• Q1 2025 consolidated revenues rose 29% to $6.4 million from $5 million in Q1 2024.

• Fuel Chem segment revenue increased 92% to $5.1 million, comprising nearly 80% of total revenues.

• APC segment revenue declined 44% to $1.3 million, mainly due to project timing and customer delays.

• Gross margin improved to 46% (Q1 2025) from 41% (Q1 2024); Fuel Chem margin at 50%, APC at 33%.

• Operating loss narrowed to $952,000 from $1.7 million; adjusted EBITDA loss improved to $735,000 from $1.5 million.

Outlook and guidance

• 2025 revenue guidance maintained at approximately $30 million, with both segments expected to exceed 2024 performance.

• Guidance excludes material DGI revenue, significant APC contributions from new regulations or large data center contracts, and new Fuel Chem business development impacts.

• Management expects cost control efforts to maintain operating expenditures and sees new business opportunities improving financial and market outlook.

• Current APC backlog is $10.3 million, with a global sales pipeline of $50–75 million.

• New demonstration of TIFI technology and DGI technology demonstration at a fish hatchery to begin in 2025, targeting first commercial DGI revenues.